Similarly, adoptive allogeneic γδ T cell therapy in late-stage lung and liver cancer patients improved the frequencies of immune cells such as CD4+, CD8+, and Vδ2 γδ T cells [40,41]. This evidence concerns the gene CD8A and liver cancer.